Unicycive Therapeutics Ownership | Who Owns Unicycive Therapeutics?


OverviewForecastFinancialsChart

Unicycive Therapeutics Ownership Summary


Unicycive Therapeutics is owned by 34.80% institutional investors, 2.93% insiders, and 62.28% retail investors. Blackrock is the largest institutional shareholder, holding 0.15% of UNCY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.68% of its assets in Unicycive Therapeutics shares.

UNCY Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockUnicycive Therapeutics34.80%2.93%62.28%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock51.84K0.15%$25.98K
Goldman sachs group73.61K0.08%$58.46K
Bank of america corp /de/223.000.00%$112.00
Silverarc capital management---
Renaissance---
Tower research capital llc (trc)---
Bvf inc/il---
Two sigma securities---
Soa wealth advisors, llc.---
Bogart wealth---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Silverarc capital management---
Bogart wealth---
Renaissance---
Blackrock51.84K-$25.98K
Tower research capital llc (trc)---
Two sigma securities---
Bvf inc/il---
Soa wealth advisors, llc.---
Scientech research---

Top Buyers

HolderShares% AssetsChange
Blackrock51.84K-51.84K
Bank of america corp /de/223.00-223.00
Bogart wealth---60.00
Jpmorgan chase---184.00
Wells fargo & company/mn---196.00

Top Sellers

HolderShares% AssetsChange
Vivo capital---11.37M
Great point partners---10.98M
Octagon capital advisors lp---10.00M
Nantahala capital management---9.39M
Logos global management lp---5.08M

New Positions

HolderShares% AssetsChangeValue
Blackrock51.84K-51.84K$25.98K
Bank of america corp /de/223.00-223.00$112.00

Sold Out

HolderChange
Bogart wealth-60.00
Jpmorgan chase-184.00
Wells fargo & company/mn-196.00
Citigroup-587.00
Soa wealth advisors, llc.-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20253066.67%6,285,92722.20%341.99%24380.00%1-92.31%
Jun 30, 202518-37.93%5,144,082-91.42%411.59%5-64.29%1362.50%
Mar 31, 20254-87.10%21,301,904-65.48%30.07%1-95.24%2-60.00%
Dec 31, 2024307.14%61,690,74431.86%692.51%20-9.09%5-
Sep 30, 20242816.67%46,786,564146.28%521.78%22100.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv469.49K3.68%-10.26K
Vanguard Institutional Extnd Mkt Idx Tr81.66K0.64%-37.21K
Fidelity Extended Market Index35.47K0.20%7.76K
Fidelity Total Market Index10.88K0.06%-22.00
iShares Micro-Cap ETF69.73K0.06%-
Vanguard Instl Ttl Stk Mkt Idx InstlPls7.34K0.06%1.00
Fidelity Series Total Market Index9.53K0.05%2.65K
Spartan Extended Market Index Pool E58.30K0.05%2.46K
Northern Trust Extended Eq Market Idx5.66K0.04%2.00
NT Ext Equity Mkt Idx Fd - L5.66K0.04%2.00

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2022Schiller Brigitte Buy$12.38K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

UNCY Ownership FAQ


Who Owns Unicycive Therapeutics?

Unicycive Therapeutics shareholders are primarily institutional investors at 34.80%, followed by 2.93% insiders and 62.27% retail investors. The average institutional ownership in Unicycive Therapeutics's industry, Biotech Stocks , is 45.22%, which Unicycive Therapeutics falls below.

Who owns the most shares of Unicycive Therapeutics?

Unicycive Therapeutics’s largest shareholders are Blackrock (51.84K shares, 0.15%), Goldman sachs group (73.61K shares, 0.08%), and Bank of america corp /de/ (223 shares, 0.00%). Together, they hold 0.23% of Unicycive Therapeutics’s total shares outstanding.

Does Blackrock own Unicycive Therapeutics?

Yes, BlackRock owns 0.15% of Unicycive Therapeutics, totaling 51.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 25.98K$. In the last quarter, BlackRock increased its holdings by 51.84K shares, a 100.00% change.

Who is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested?

Geode capital management is Unicycive Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Unicycive Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Unicycive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Unicycive Therapeutics shares, with 3.68% of its total shares outstanding invested in 469.49K Unicycive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools